OACC
Oaktree Acquisition Corp. III Life Sciences
10.70$
+0.0%
vs. previous close
Closing price · As of: Nov 11, 2026
Filings
Filings
Listed US companies must report material events to the Securities and Exchange Commission. This page lists the filings of Oaktree Acquisition Corp. III Life Sciences (OACC) with date, type and a link to the original document.
| Date | Type | Filing | Original |
|---|---|---|---|
| 10/26/2026 | Current report (8-K) | Oaktree Acquisition Corp. III Life Sciences (OACC): Unregistered Sales of Equity Securities; Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year; Submission of Matters to a Vote of Security Holders; Financial Statements and Exhibits | View report ↗ |
| 10/16/2026 | Current report (8-K) | Oaktree Acquisition Corp. III Life Sciences (OACC): Regulation FD Disclosure | View report ↗ |
| 10/15/2026 | Current report (8-K) | Oaktree Acquisition Corp. III Life Sciences (OACC): Regulation FD Disclosure | View report ↗ |
Showing the 100 most recent filings of the selected type.
Data as of: November 11, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Filings: SEC EDGAR
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.